June 24, 2024
Image default

U.S. delays decision on COVID vaccine for children under 5 by at least 2 months

Published by

By Ankur Banerjee and Michael Erman (Reuters) – A U.S. decision on Pfizer and BioNTech’s COVID-19 vaccine for children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration said it needed more data. The FDA had planned to make a decision on the vaccine based on early trial data because of what it had called a great public health need due to the surge in infections caused by the Omicron variant of the coronavirus. The decision was slated for next week with a rollout starting as soon as Feb. 21. On Friday, the agency said it had reviewe…

Read More

Related posts

GOP Rep. Meijer receiving threats after ‘vote of conscience’ to impeach Trump


U.S. Senate to vote Tuesday on raising government’s debt limit


Queen Elizabeth II, Longest Reigning Monarch Of Britain, Dies Aged 96


Senate panel opens hearing on historic U.S. Supreme Court pick Jackson


Kansas abortion vote rocks US midterms outlook


Martin Luther King’s family joins call for US voting reform


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.